Abstract Objective This study was aimed to investigate the effect of polymyxin B-immobilized fiber column (PMX) hemoperfusion treatment on the acute exacerbation of idiopathic pulmonary fibrosis (IPF).
Introduction

Idiopathic interstitial pneumonias (IIPs) represent a heterogenous group of diffuse parenchymal lung disorders of unknown etiology. Idiopathic pulmonary fibrosis (IPF) is among the most common IIP and is characterized by clinically progressive dyspnea and worsening of pulmonary function (1, 2). Some IPF patients have acute exacerbations generally characterized by severe respiratory failure and pathological lesions of diffuse alveolar damage (DAD)
. Mortality of these patients with acute exacerbation has been reported to be high during their hospitalization (4) (5) (6) . (9) (10) (11) (8, 9, 13 i g u r e 1 . S e r i a l Aa DO2 a n d s e r u m L DH v a l u e s p r e -a n d p o s t -P MX t r e a t me n t ( c a s e s 1 -6 ) . P MX t r e a t me n t r e s u l t e d i n i mp r o v e d Aa DO2 a n d s e r u m L DH i n f o u r ( c a s e s 1 , 2 , 5 a n d 6 ) o f s i x p a t i e n t s wi t h a c u t e e x a c e r b a t i o n o f c l i n i c a l I P F .
Polymyxin B-immobilized fiber (PMX) treatment has been reported to be effective in both gram-negative and gram-positive sepsis (8). Recent reports have suggested that PMX treatment may improve oxygenation in patients with acute lung injury (ALI)/acute respiratory distress syndrome (ARDS)
T 
F i g u r e 2 . Ch e s t X-r a y a n d HRCT o f c a s e 1 . ( A) Ch e s t X-r a y s h o ws b i l a t e r a l i n f i l t r a t i o n i n t h e l o we r l u n g a t t h e t i me o f a c u t e e x a c e r b a t i o n o f c l i n i c a l I P F . ( B ) Ch e s t X-r a y s h o ws i mp r o v e d b i l a te r a l i n f i l t r a t i o n , a n d a n i n c r e a s e i n l u n g v o l u me a f t e r t r e a t me n t wi t h P MX t r e a t me n t f i v e t i me s . ( C) Re t i c u l a r a n d l i n e a r p a t t e r n s wi t h t r a c t i o n b r o n c h o e c t a s i s a n d g r o u n d g l a s s a t t e n u a t i o n we r e o b s e r v e d i n t h e a c u t e e x a c e r b a t i o n o f I P F ( b e f o r e P MX t r e a t me n t ) . ( D) Gr o u n d g l a s s a t t e n u a t i o n wa s r e s o l v e d a f t e r P MX t r e a t me n t .
F i g u r e 3 . S e r u m KL -6 l e v e l s p r e -a n d p o s t -P MX-t r e a t me n t i n c l i n i c a l I P F p a t i e n t s wi t h a c u t e e x a c e r b a t i o n . S e r u m KL -6 l e v e l s p o s t P MX we r e n o t e v a l u a t e d i n c a s e s 3 a n d 4 . (Fig. 1A) . Diffuse ground glass attenuation of HRCT resolved after five times treatment with PMX in case 1 (Fig. 2) 1E) and 6 (Fig. 1F) , we administered PMX treatment twice for 2 hours as originally described (8, 9) . AaDO2 and LDH were improved and these patients were weaned from mechanical ventilation and survived more than 30 days post PMX treatment. In the four of six patients who survived, serum KL-6 levels decreased in response to PMX treatment (Fig. 3) .
hours each. Acute hypoxemic respiratory failure assessed by AaDO2, P/F ratio, serum LDH and KL-6 gradually improved after each PMX treatment
Discussion
In (17) . Acute exacerbations of IPF have been described high mortality in several reports (4, 5, 7, 18 (10) . In an animal model of sepsis, PMX has been reported to improve oxygenation through suppression of nitric oxide production (19 (8) . Additionally, PMX treatment once or twice for 4 hours has reportedly improved the survival of sepsis patients (13) . A recent paper has suggested that frequent treatment might be effective in severe sepsis patients (25) 
